1 News from the research and development department by GILEAD Sciences

1 News from the research and development department by GILEAD Sciences

Gilead Reduces Prices for Viread® and Truvada® in the Developing World

31-Aug-2005 - Gilead Sciences, Inc. announced a significant price reduction for Viread® (tenofovir disoproxil fumarate) and Truvada® (emtricitabine and tenofovir disoproxil fumarate) made available through the company's Access Program in the developing world. Both once-a-day antiretroviral medications for HIV ...

active pharmaceutical ingredients AIDS reductions
Haven't found the right news yet?

The chemeurope.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 27,117 chemistry news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now